Efficacy and safety of <scp>DL</scp>‐3‐N‐butylphthalide in the treatment of ischemic poststroke aphasia: A randomized clinical trial
NBP treatment might promote the recovery of WAB-AQ in patients with ischemic PSA by increasing levels of monoamine neurotransmitters.
Authors
- Ruihan Miao
- Ruomeng Chen
- Xiaoyun Liu (ORCID: https://orcid.org/0009-0003-8604-904X)
- Lijuan Liu (ORCID: https://orcid.org/0009-0005-2617-5858)
- Jing Tian (ORCID: https://orcid.org/0000-0003-3396-276X)
- Binbin Wang (ORCID: https://orcid.org/0000-0003-3270-0856)
- Rui Wang (ORCID: https://orcid.org/0000-0002-7974-9510)
- Haoran Wu (ORCID: https://orcid.org/0000-0001-9449-6112)
- Jianing Yang (ORCID: https://orcid.org/0009-0002-8661-3475)
- Li Guo (ORCID: https://orcid.org/0000-0002-5861-4916)
- Biyi Zhou
- Kun Zhang (ORCID: https://orcid.org/0000-0002-1088-5813)
- Peng Yang (ORCID: https://orcid.org/0009-0006-7637-7885)
Institutions
- Hebei Medical University (CN)
- Second Hospital of Hebei Medical University (CN)
- First Affiliated Hospital of Hebei Medical University (CN)
Publication Details
- Journal
- Annals of Clinical and Translational Neurology
- Published
- 2024-11-22
- DOI
- https://doi.org/10.1002/acn3.52238
- Citations
- 2
- Primary Topic
- Neurological Disease Mechanisms and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.49
Funders
- Major Research Plan